Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Koninklijke Philips (PHG) Finished Goods (2016 - 2023)

Koninklijke Philips' quarterly Finished Goods came in at $1.8 billion in Q4 2023, down 7.64% year-on-year from $1.9 billion in Q4 2022, and down 7.64% quarter-over-quarter from $1.9 billion in Q4 2022.

Koninklijke Philips has reported Finished Goods for 8 years, with the latest figure at $1.8 billion in Q4 2023.

  • For the quarter ending Q4 2023, Finished Goods fell 7.64% year-over-year to $1.8 billion; the trailing twelve-month figure through Dec 2023 stood at $1.8 billion (down 7.64% YoY), and the FY2023 full-year result was $1.8 billion, down 7.64% from the prior year.
  • Finished Goods for Q4 2023 stood at $1.8 billion, down from $1.9 billion in the prior quarter.
  • The five-year high for Finished Goods was $1.9 billion in Q4 2021, with the low at $1.6 billion in Q4 2019.
  • Average Finished Goods over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2023.
  • Year-over-year, Finished Goods advanced 8.79% in 2021 and slipped 7.64% in 2023.
  • Tracing PHG's Finished Goods over 5 years: stood at $1.6 billion in 2019, then grew by 7.35% to $1.7 billion in 2020, then grew by 8.79% to $1.9 billion in 2021, then retreated by 0.07% to $1.9 billion in 2022, then retreated by 7.64% to $1.8 billion in 2023.
  • The last three Finished Goods figures came in at $1.8 billion (Q4 2023), $1.9 billion (Q4 2022), and $1.9 billion (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 1.75 Bn
Dec 31, 2022 1.90 Bn
Dec 31, 2021 1.90 Bn
Dec 31, 2020 1.75 Bn
Dec 31, 2019 1.63 Bn
Dec 31, 2018 1.63 Bn
Dec 31, 2017 1.51 Bn
Dec 31, 2016 2.06 Bn